With support from the Bill & Melinda Gates Foundation, FHI 360 has launched a project to support early testing of innovative approaches to developing a longer-acting injectable contraceptive (that lasts 6 to 12 months). This project is the first step toward bringing a game-changing injectable contraceptive to market, thereby expanding contraceptive access and choice for women around the world.
Development of Longer-Acting Injectable Contraceptive; First stage of application due April 30
